Ocrevus (ocrelizumab) [Genentech]
- Relapsing or Primary Progressive Multiple Sclerosis
- Initial dose: 300mg IV at Day 1 & Day 15
- Subsequent doses: 600mg q 6 months
- Need Hepatitis B S Ag
- All immunizations given at least 6 weeks prior to initiating therapy
- Please open authorization forms at left. Fill out the forms on your computer, save and print.
- Open Physician Orders for the office of your choice (at left). Save to your computer, print and fill out.
- The following tests should be performed and test results faxed to Pacific Infusion before the patient’s first visit:
Ocrelizumab – CXR, Hepatitis B virus (HBV) screening
- Fax the completed, signed forms and a copy of the patient’s insurance card to: Pacific Infusion Center (310) 297-9222.
- After the patient’s infusion appointment, one of our nurses will fax a copy of the infusion notes to your office.